AI assistant
Transgene — Share Issue/Capital Change 2023
Jan 17, 2023
1715_rns_2023-01-17_c888bb91-82d6-4b36-83e5-94fa3aacc3ca.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
PRESS RELEASE
Balance sheet of the liquidity contract with Natixis Oddo BHF SCA as of December 31, 2022
Strasbourg, January 17, 2023 – 05:45 pm CET
Under the liquidity contract entrusted by Transgene to Natixis Oddo BHF SCA, as of December 31, 2022, the following resources were managed through the liquidity account:
- 286,436 shares
- € 123,251.00
In the second half of 2022, a total of:
| Purchases | 230,148 shares |
€ 467,081 | 800 market transactions |
|---|---|---|---|
| Sales | 173,969 shares |
€ 362,798 | 714 market transactions |
It is recalled that when the liquidity program was initially established in 2016, the following resources were made available:
Cash balance of the liquidity contract: € 500,000.00
At the time the liquidity program was transferred to Natixis Oddo BHF SCA on January 2, 2020, the resources managed through the liquidity account consisted of:
- 164,183 shares
- € 246,158.00
Contacts
Transgene:
Jean-Philippe Del CFO +33 (0)3 88 27 91 00 [email protected]